Feral and wild-type methicillin-resistant Staphylococcus aureus in the United Kingdom

Epidemiology and Infection

Volumn 138, Issue 5, 2010, Pages 655-665

  Miller, R ^a   Walker, A S ^b   Knox, K ^b   Wyllie, D ^a   Paul, J ^c   Haworth, E ^d   Mant, D ^b   Peto, T ^a   Crook, D W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Worthing Hospital   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Community; MRSA; Nosocomial

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; NETILMICIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN; VIRULENCE FACTOR;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; COMMUNITY; FEMALE; GENE LOCUS; GENE SEQUENCE; HEALTH CARE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTOR; UNITED KINGDOM; ADOLESCENT; BACTERIUM IDENTIFICATION; CHEMISTRY; CLASSIFICATION; COMMUNICABLE DISEASE; DNA FINGERPRINTING; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; CIPROFLOXACIN; COMMUNITY-ACQUIRED INFECTIONS; DNA FINGERPRINTING; DNA, BACTERIAL; EXOTOXINS; FEMALE; GREAT BRITAIN; HUMANS; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; VIRULENCE FACTORS; YOUNG ADULT;

EID: 77950874036     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809991294     Document Type: Article

References (20)

1. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. Journal of Antimicrobial Chemotherapy 2005; 56: 455-462.
2. Beasley C, Florey D. MRSA screening - Operational Guidance 2: Department of Health, 2008 [Letter].
3. Cooper BS, et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proceedings of the National Academy of Sciences USA 2004; 101: 10223-10228.
4. Bootsma MC, Diekmann O, Bonten MJ. Controlling methicillin-resistant Staphylococcus aureus : quantifying the effects of interventions and rapid diagnostic testing. Proceedings of the National Academy of Sciences USA 2006; 103: 5620-5625.
5. Bhattacharya D, et al. Differences in clinical and molecular characteristics of skin and soft tissue methicillinresistant Staphylococcus aureus isolates between two hospitals in Northern California. Journal of Clinical Microbiology 2007; 45: 1798-1803.
6. Groom AV, et al. Community-acquired methicillinresistant Staphylococcus aureus in a rural American Indian community. Journal of the American Medical Association 2001; 286: 1201-1205.
7. Hussain FM, Boyle-Vavra S, Daum RS. Communityacquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic. Pediatric Infectious Disease Journal 2001; 20: 763-767.
8. Carleton HA, et al. Community-adapted methicillinresistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. Journal of Infectious Diseases 2004; 190: 1730-1738.
9. Millar BC, et al. Proposed definitions of communityassociated meticillin-resistant Staphylococcus aureus (CA-MRSA). Journal of Hospital Infection 2007; 67: 109-113.
10. HMSO. The Health Service (Control of Patient Information) Regulations 2002. (http://www.opsi.gov. uk/si/si2002/20021438.htm)
11. Standards Unit, Centre for Clinical Infections. Identification of Staphylococcus species, Micrococcus species and Rothia species. National Standard Method: BSOP ID: 7i2.1. 2007.
12. McClure JA, et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. Journal of Clinical Microbiology 2006; 44: 1141-1144.
13. Miller R, et al. Is MRSA admission bacteraemia community- acquired? A case control study. Journal of Infection 2008; 56: 163-170.
14. Enright MC, et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillinsusceptible clones of Staphylococcus aureus. Journal of Clinical Microbiology 2000; 38: 1008-1015
15. Harmsen D, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. Journal of Clinical Microbiology 2003; 41: 5442-5448.
16. Gomes AR, Westh H, de Lencastre H. Origins and evolution of methicillin-resistant Staphylococcus aureus clonal lineages. Antimicrobial Agents Chemotherapy 2006; 50: 3237-3244.
17. Pan ES, et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus - and their relation to community-associated disease activity. Journal of Infectious Disease 2005; 192: 811-818.
18. Maudsley J, et al. The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes: implications for treatment, screening and surveillance in the UK. Journal of Hospital Infection 2004; 57: 258-262.
19. Wyllie DH, Peto TE, Crook D. MRSA bacteraemia in patients on arrival in hospital : a cohort study in Oxfordshire 1997-2003. British Medical Journal 2005; 331: 992.
20. Atkinson SR, et al. The emergence of meticillin-resistant Staphylococcus aureus among injecting drug users. Journal of Infection 2009; 58: 339..